Cargando…

Mitigation of Ionizing Radiation-Induced Gastrointestinal Damage by Insulin-Like Growth Factor-1 in Mice

Purpose: Insulin-like growth factor-1 (IGF-1) stimulates epithelial regeneration but may also induce life-threatening hypoglycemia. In our study, we first assessed its safety. Subsequently, we examined the effect of IGF-1 administered in different dose regimens on gastrointestinal damage induced by...

Descripción completa

Detalles Bibliográficos
Autores principales: Pejchal, Jaroslav, Tichy, Ales, Kmochova, Adela, Fikejzlova, Lenka, Kubelkova, Klara, Milanova, Marcela, Lierova, Anna, Filipova, Alzbeta, Muckova, Lubica, Cizkova, Jana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277384/
https://www.ncbi.nlm.nih.gov/pubmed/35847048
http://dx.doi.org/10.3389/fphar.2022.663855
_version_ 1784745967067594752
author Pejchal, Jaroslav
Tichy, Ales
Kmochova, Adela
Fikejzlova, Lenka
Kubelkova, Klara
Milanova, Marcela
Lierova, Anna
Filipova, Alzbeta
Muckova, Lubica
Cizkova, Jana
author_facet Pejchal, Jaroslav
Tichy, Ales
Kmochova, Adela
Fikejzlova, Lenka
Kubelkova, Klara
Milanova, Marcela
Lierova, Anna
Filipova, Alzbeta
Muckova, Lubica
Cizkova, Jana
author_sort Pejchal, Jaroslav
collection PubMed
description Purpose: Insulin-like growth factor-1 (IGF-1) stimulates epithelial regeneration but may also induce life-threatening hypoglycemia. In our study, we first assessed its safety. Subsequently, we examined the effect of IGF-1 administered in different dose regimens on gastrointestinal damage induced by high doses of gamma radiation. Material and methods: First, fasting C57BL/6 mice were injected subcutaneously with IGF-1 at a single dose of 0, 0.2, 1, and 2 mg/kg to determine the maximum tolerated dose (MTD). The glycemic effect of MTD (1 mg/kg) was additionally tested in non-fasting animals. Subsequently, a survival experiment was performed. Animals were irradiated ((60)Co; 14, 14.5, or 15 Gy; shielded head), and IGF-1 was administered subcutaneously at 1 mg/kg 1, 24, and 48 h after irradiation. Simultaneously, mice were irradiated ((60)Co; 12, 14, or 15 Gy; shielded head), and IGF-1 was administered subcutaneously under the same regimen. Jejunum and lung damage were assessed 84 h after irradiation. Finally, we evaluated the effect of six different IGF-1 dosage regimens administered subcutaneously on gastrointestinal damage and peripheral blood changes in mice 6 days after irradiation ((60)Co; 12 and 14 Gy; shielded head). The regimens differed in the number of doses (one to five doses) and the onset of administration (starting at 1 [five regimens] or 24 h [one regimen] after irradiation). Results: MTD was established at 1 mg/kg. MTD mitigated lethality induced by 14 Gy and reduced jejunum and lung damage caused by 12 and 14 Gy. However, different dosing regimens showed different efficacy, with three and four doses (administered 1, 24, and 48 h and 1, 24, 48, and 72 h after irradiation, respectively) being the most effective. The three-dose regimens supported intestinal regeneration even if the administration started at 24 h after irradiation, but its potency decreased. Conclusion: IGF-1 seems promising in the mitigation of high-dose irradiation damage. However, the selected dosage regimen affects its efficacy.
format Online
Article
Text
id pubmed-9277384
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92773842022-07-14 Mitigation of Ionizing Radiation-Induced Gastrointestinal Damage by Insulin-Like Growth Factor-1 in Mice Pejchal, Jaroslav Tichy, Ales Kmochova, Adela Fikejzlova, Lenka Kubelkova, Klara Milanova, Marcela Lierova, Anna Filipova, Alzbeta Muckova, Lubica Cizkova, Jana Front Pharmacol Pharmacology Purpose: Insulin-like growth factor-1 (IGF-1) stimulates epithelial regeneration but may also induce life-threatening hypoglycemia. In our study, we first assessed its safety. Subsequently, we examined the effect of IGF-1 administered in different dose regimens on gastrointestinal damage induced by high doses of gamma radiation. Material and methods: First, fasting C57BL/6 mice were injected subcutaneously with IGF-1 at a single dose of 0, 0.2, 1, and 2 mg/kg to determine the maximum tolerated dose (MTD). The glycemic effect of MTD (1 mg/kg) was additionally tested in non-fasting animals. Subsequently, a survival experiment was performed. Animals were irradiated ((60)Co; 14, 14.5, or 15 Gy; shielded head), and IGF-1 was administered subcutaneously at 1 mg/kg 1, 24, and 48 h after irradiation. Simultaneously, mice were irradiated ((60)Co; 12, 14, or 15 Gy; shielded head), and IGF-1 was administered subcutaneously under the same regimen. Jejunum and lung damage were assessed 84 h after irradiation. Finally, we evaluated the effect of six different IGF-1 dosage regimens administered subcutaneously on gastrointestinal damage and peripheral blood changes in mice 6 days after irradiation ((60)Co; 12 and 14 Gy; shielded head). The regimens differed in the number of doses (one to five doses) and the onset of administration (starting at 1 [five regimens] or 24 h [one regimen] after irradiation). Results: MTD was established at 1 mg/kg. MTD mitigated lethality induced by 14 Gy and reduced jejunum and lung damage caused by 12 and 14 Gy. However, different dosing regimens showed different efficacy, with three and four doses (administered 1, 24, and 48 h and 1, 24, 48, and 72 h after irradiation, respectively) being the most effective. The three-dose regimens supported intestinal regeneration even if the administration started at 24 h after irradiation, but its potency decreased. Conclusion: IGF-1 seems promising in the mitigation of high-dose irradiation damage. However, the selected dosage regimen affects its efficacy. Frontiers Media S.A. 2022-06-29 /pmc/articles/PMC9277384/ /pubmed/35847048 http://dx.doi.org/10.3389/fphar.2022.663855 Text en Copyright © 2022 Pejchal, Tichy, Kmochova, Fikejzlova, Kubelkova, Milanova, Lierova, Filipova, Muckova and Cizkova. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Pejchal, Jaroslav
Tichy, Ales
Kmochova, Adela
Fikejzlova, Lenka
Kubelkova, Klara
Milanova, Marcela
Lierova, Anna
Filipova, Alzbeta
Muckova, Lubica
Cizkova, Jana
Mitigation of Ionizing Radiation-Induced Gastrointestinal Damage by Insulin-Like Growth Factor-1 in Mice
title Mitigation of Ionizing Radiation-Induced Gastrointestinal Damage by Insulin-Like Growth Factor-1 in Mice
title_full Mitigation of Ionizing Radiation-Induced Gastrointestinal Damage by Insulin-Like Growth Factor-1 in Mice
title_fullStr Mitigation of Ionizing Radiation-Induced Gastrointestinal Damage by Insulin-Like Growth Factor-1 in Mice
title_full_unstemmed Mitigation of Ionizing Radiation-Induced Gastrointestinal Damage by Insulin-Like Growth Factor-1 in Mice
title_short Mitigation of Ionizing Radiation-Induced Gastrointestinal Damage by Insulin-Like Growth Factor-1 in Mice
title_sort mitigation of ionizing radiation-induced gastrointestinal damage by insulin-like growth factor-1 in mice
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277384/
https://www.ncbi.nlm.nih.gov/pubmed/35847048
http://dx.doi.org/10.3389/fphar.2022.663855
work_keys_str_mv AT pejchaljaroslav mitigationofionizingradiationinducedgastrointestinaldamagebyinsulinlikegrowthfactor1inmice
AT tichyales mitigationofionizingradiationinducedgastrointestinaldamagebyinsulinlikegrowthfactor1inmice
AT kmochovaadela mitigationofionizingradiationinducedgastrointestinaldamagebyinsulinlikegrowthfactor1inmice
AT fikejzlovalenka mitigationofionizingradiationinducedgastrointestinaldamagebyinsulinlikegrowthfactor1inmice
AT kubelkovaklara mitigationofionizingradiationinducedgastrointestinaldamagebyinsulinlikegrowthfactor1inmice
AT milanovamarcela mitigationofionizingradiationinducedgastrointestinaldamagebyinsulinlikegrowthfactor1inmice
AT lierovaanna mitigationofionizingradiationinducedgastrointestinaldamagebyinsulinlikegrowthfactor1inmice
AT filipovaalzbeta mitigationofionizingradiationinducedgastrointestinaldamagebyinsulinlikegrowthfactor1inmice
AT muckovalubica mitigationofionizingradiationinducedgastrointestinaldamagebyinsulinlikegrowthfactor1inmice
AT cizkovajana mitigationofionizingradiationinducedgastrointestinaldamagebyinsulinlikegrowthfactor1inmice